tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MRKR Stock Latest News

Marker Therapeutics Reports Increased R&D Expenses Amid Revenue Decline
Company AnnouncementsMarker Therapeutics Reports Increased R&D Expenses Amid Revenue Decline
2d ago
MRKR
Promising Developments and Market Potential Drive Buy Rating for Marker Therapeutics
PremiumRatings
Promising Developments and Market Potential Drive Buy Rating for Marker Therapeutics
4d ago
MRKR
Strategic Collaborations and Promising Clinical Developments Drive Buy Rating for Marker Therapeutics
PremiumRatings
Strategic Collaborations and Promising Clinical Developments Drive Buy Rating for Marker Therapeutics
2M ago
MRKR
Marker Therapeutics Partners with Cellipont for MT-601 Manufacturing
PremiumCompany Announcements
Marker Therapeutics Partners with Cellipont for MT-601 Manufacturing
2M ago
8K
MRKR
Marker, Cellpoint announce collaboration for cGMP manufacturing of MT-601
PremiumThe Fly
Marker, Cellpoint announce collaboration for cGMP manufacturing of MT-601
2M ago
MRKR
Marker Therapeutics Concludes Annual Stockholders Meeting
PremiumCompany AnnouncementsMarker Therapeutics Concludes Annual Stockholders Meeting
2M ago
8K
MRKR
Marker Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Marker Therapeutics Reports Q1 2025 Financial Results
2M ago
MRKR
Buy Rating Maintained for Marker Therapeutics Due to Promising MT-601 Developments and APOLLO Study Progress
Premium
Ratings
Buy Rating Maintained for Marker Therapeutics Due to Promising MT-601 Developments and APOLLO Study Progress
3M ago
MRKR
Marker Therapeutics Reports Positive Impact of Lymphodepletion on MAR-T Cells
PremiumCompany Announcements
Marker Therapeutics Reports Positive Impact of Lymphodepletion on MAR-T Cells
3M ago
MRKR
Marker Therapeutics reports evidence from Phase 1 APOLLO study
PremiumThe Fly
Marker Therapeutics reports evidence from Phase 1 APOLLO study
3M ago
MRKR
Marker Therapeutics Advances T Cell Therapies in 2024
PremiumCompany Announcements
Marker Therapeutics Advances T Cell Therapies in 2024
4M ago
MRKR
Marker Therapeutics: Strong Buy Rating Backed by Innovative MAR-T Cell Therapy and Robust Financial Position
PremiumRatings
Marker Therapeutics: Strong Buy Rating Backed by Innovative MAR-T Cell Therapy and Robust Financial Position
5M ago
MRKR
Marker Therapeutics Advances MT-601 with Promising Results and Strategic Funding
PremiumCompany AnnouncementsMarker Therapeutics Advances MT-601 with Promising Results and Strategic Funding
5M ago
MRKR
Marker Therapeutics reports FY24 EPS ($1.19) vs ($1.59) last year
Premium
The Fly
Marker Therapeutics reports FY24 EPS ($1.19) vs ($1.59) last year
5M ago
MRKR
Marker Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Marker Therapeutics initiated with a Buy at Canaccord
5M ago
MRKR
Marker Therapeutics initiated with a Buy at Canaccord
PremiumThe Fly
Marker Therapeutics initiated with a Buy at Canaccord
5M ago
MRKR
Marker Therapeutics Grants Stock Options to Directors
PremiumCompany Announcements
Marker Therapeutics Grants Stock Options to Directors
6M ago
8K
MRKR
Marker Therapeutics initiated with a Buy at Brookline
PremiumThe Fly
Marker Therapeutics initiated with a Buy at Brookline
6M ago
MRKR
Marker Therapeutics files to sell 10.06M shares of common stock for holders
PremiumThe Fly
Marker Therapeutics files to sell 10.06M shares of common stock for holders
7M ago
MRKR
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
8M ago
MRK
NVO
Marker Therapeutics sells 5.03M shares at $3.20 in private placement
Premium
The Fly
Marker Therapeutics sells 5.03M shares at $3.20 in private placement
8M ago
MRKR
Marker Therapeutics provides update on MT-601 patients
Premium
The Fly
Marker Therapeutics provides update on MT-601 patients
8M ago
MRKR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >